Daily cost of glaucoma medications in China.
Gao Ying, Wu Lingling, Li Aijun
AI Summary
This study quantified daily glaucoma medication costs in China, finding wide variations (e.g., prostaglandins are expensive). This data is crucial for clinicians and patients selecting cost-effective treatments.
Abstract
Purpose
To determine and compare the daily cost of various glaucoma medications in China.
Materials and methods
The majority of glaucoma medications commercially available in China were included in this research. The total number of drops in 1 bottle of each medication was counted drop by drop. The mean volume per bottle of each medication was calculated. The cost per drop, number of days for both eyes usage per bottle, and daily cost was calculated.
Results
(1) The volume per drop ranged from 0.03 mL (brinzolamide 1%, travoprost 0.004%, bimatoprost 0.03%, and latanoprost 0.005%) to 0.05 mL (timolol 0.5%-Chengrui and pilocarpine 0.5% and 2%-Zhenrui). (2) The cost per bottle ranged from $0.69 (US dollar) (timolol 0.5%-Malaisuan Saimaluo'er) to $40.78 (latanoprost 0.005%). (3) The number of days for both eyes usage per bottle ranged from 52 days (bimatoprost 0.03%) to 11 days (pilocarpine nitrate 0.5%-Zhenrui). (4) The daily cost for both eyes usage from expensive to cheap were latanoprost 0.005%-$0.91, travoprost 0.004%-$0.77, brimonidine 0.2%-$0.61, bimatoprost 0.03%-$0.46, D-timolol 1%-$0.36, brinzolamide 1%-$0.34, pilocarpine 2%-Zhenrui-$0.28, levobunolol 0.5%-$0.25, betaxolol 0.25%-$0.24, pilocarpine 0.5%-Zhenrui-$0.18, pilocarpine 2%-Huming-$0.16, carteolol 1%-Mikelan-$0.15, carteolol 2%-Mikelan-$0.15, pilocarpine 1%-Huming-$0.10, timolol 0.5%-Chengrui-$0.08, timolol 0.5%-Malaisuan Saimaluo'er-$0.03.
Conclusions
The daily cost of glaucoma medications in China ranged much more wildly than developed countries. These data may be useful in selecting medications for glaucoma therapy. The ophthalmic solution of prostaglandins is powerful in reducing intraocular pressure. However, its high price should be considered when selecting glaucoma medications in China.
MeSH Terms
Shields Classification
Related Articles5
Impact of neighborhood-level deprivation on glaucoma prevalence and treatment: A review of the literature.
Systematic ReviewSymptomatic Presbyopia may Develop Earlier in Patients With Glaucoma-A Cross-Sectional Retrospective Cohort Study.
Cross-Sectional StudyPatients' Acceptance of Glaucoma Therapy in Sub-Saharan Africa.
Cross-Sectional StudyLong-Term Effect of Systemic Comorbidity on Glaucoma Medication Adherence.
Cohort StudyThe Effect of Insurance Coverage Laws on Glaucoma Eyedrop Medication Usage.
Observational StudyIs this article assigned to the wrong chapter(s)? Let us know.